AN EFFICACY, SAFETY AND TOLERABILITY STUDY OF GLATIRAMER ACETATE (GA) 20 MG/0.5 ML NEW FORMULATION ADMINISTERED DAILY BY SUBCUTANEOUS (SC) INJECTION IN SUBJECTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS):